<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-27T21:42:11Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/6085" metadataPrefix="didl">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/6085</identifier><datestamp>2021-06-23T09:51:38Z</datestamp><setSpec>com_10324_1134</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1213</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2015-09-19T23:40:08Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10324_6085">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10324/6085</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems</dc:title>
<dc:creator>Bajo Grañeras, Raquel</dc:creator>
<dc:creator>Ganfornina Álvarez, María Dolores</dc:creator>
<dc:creator>Martín Tejedor, Esperanza</dc:creator>
<dc:creator>Sánchez Romero, Diego</dc:creator>
<dc:subject>Sistema nervioso central - Enfermedades</dc:subject>
<dc:description>Producción Científica</dc:description>
<dc:description>The study of glial derived factors induced by injury and&#xd;
degeneration is important to understand the nervous system&#xd;
response to deteriorating conditions. We focus on Apolipoprotein&#xd;
D (ApoD), a Lipocalin expressed by glia and&#xd;
strongly induced upon aging, injury or neurodegeneration.&#xd;
Here we study ApoD function in the brain of wild type and&#xd;
ApoD-KO mice by combining in vivo experiments with&#xd;
astrocyte cultures. Locomotor performance, dopamine concentration,&#xd;
and gene expression levels in the substantia&#xd;
nigra were assayed in mice treated with paraquat (PQ). The&#xd;
regulation of ApoD transcription, a molecular screening of&#xd;
oxidative stress (OS)-related genes, cell viability and oxidation&#xd;
status, and the effects of adding human ApoD were&#xd;
tested in astrocyte cultures. We demonstrate that (1) ApoD&#xd;
is required for an adequate locomotor performance, modifies&#xd;
the gene expression profile of PQ-challenged nigrostriatal&#xd;
system, and contributes to its functional maintenance; (2)&#xd;
ApoD expression in astrocytes is controlled by the OSresponsive&#xd;
JNK pathway; (3) ApoD contributes to an&#xd;
autocrine protecting mechanism in astrocytes, avoiding peroxidated&#xd;
lipids accumulation and altering the PQ transcriptional&#xd;
response of genes involved in ROS managing and the&#xd;
inflammatory response to OS; (4) Addition of human ApoD&#xd;
to ApoD-KO astrocytes promotes survival through a mechanism&#xd;
accompanied by protein internalization and modulation&#xd;
of astroglial reactivity. Our data support that ApoD&#xd;
contributes to the endurance of astrocytes and decreases&#xd;
their reactivity level in vitro and in vivo. ApoD function as&#xd;
a maintenance factor for astrocytes would suffice to explain&#xd;
the observed protection by ApoD of OS-vulnerable dopaminergic&#xd;
circuits in vivo.</dc:description>
<dc:date>2014-09-19T11:17:47Z</dc:date>
<dc:date>2015-09-19T23:40:08Z</dc:date>
<dc:date>2011</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>Glia, 2011, vol. 59, p. 1551-1566</dc:identifier>
<dc:identifier>0894-1491</dc:identifier>
<dc:identifier>http://uvadoc.uva.es/handle/10324/6085</dc:identifier>
<dc:identifier>10.1002/glia.21200</dc:identifier>
<dc:identifier>1551</dc:identifier>
<dc:identifier>1566</dc:identifier>
<dc:identifier>Glia</dc:identifier>
<dc:identifier>59</dc:identifier>
<dc:language>eng</dc:language>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
<dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
<dc:publisher>Wiley-Liss</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10324_6085_1">
<d:Resource ref="https://uvadoc.uva.es/bitstream/10324/6085/1/S%c3%81NCHEZ%209.pdf" mimeType="application/pdf"/>
</d:Component>
</d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>